India is set to receive over Rs. 52,32,600 crore (US$ 600 billion) in alternative investments in three years, boosting startups, innovation, and entrepreneurship, experts said at an IMT event.

India’s real estate sector is booming, with US$ 7.15 billion invested in land acquisitions over the past year, covering 2,335 acres across 23 cities for 194 million sq. ft of developments.

According to government data, India’s retail inflation fell to a seven-month low of 3.61% in February 2025, dropping below RBI’s 4% target as food prices eased.

Quick commerce now dominates 70%-75% of e-grocery orders, doubling from 2022, driven by strong execution, higher incomes, a wider product range, and growing demand for convenience, per Bain & Company.

India's industrial production grew 5.0% in January 2025, up from 3.2% in December, driven by manufacturing (5.5%), mining (4.4%), and electricity (2.4%), with strong gains in metals and electrical ...

Prime Minister Mr. Narendra Modi and Prime Minister of Mauritius Navinchandra Ramgoolam held productive talks, reaffirming their unique ties and strengthening the Comprehensive Strategic Partnership ...

India’s venture capital funding surged 43% YoY to US$ 13.7 billion in 2024, with deal activity up 45%, solidifying its position as Asia-Pacific’s second-largest market.

Prime Minister Mr. Narendra Modi received Mauritius' highest civilian honour, Grand Commander of the Order of the Star and Key of the Indian Ocean (GCSK), reinforcing strong India-Mauritius ties and ...

India ranked 11th in global pharmaceutical exports in 2023, contributing 3%, while regulators have intensified quality checks, inspected 905 units, and taken 694 enforcement actions since December ...

India’s data centre capacity is set to nearly double to 2,000 plus megawatts by 2027, driven by Artificial Intelligence, 5G, cloud adoption, and data localisation initiatives.

India’s Net Employment Outlook for Q2 2025 stands at 43%, leading globally, driven by strong hiring in Information Technology, healthcare, and industrial sectors.

Biosimilars — nearly identical and more affordable alternatives to biologics — can significantly lower treatment costs by 50–75%.